Painkillers..get the right one for you

The company that sells Nurofen has been fined more than $1 million for misleading consumers about its specific pain products. The Federal Court previously decided that Reckitt Benckiser, which sells market-leading ibuprofen medication including Nurofen Specific Pain Relief products, had engaged in misleading conduct by advertising that its products were specifically formulated to treat back pain, period pain, migraine pain and tension headaches over four years, when they all had the same active ingredient of ibuprofen lysine. More in this interview with pharmasist Sami Tadros